Kenneth M. Reali's most recent trade in Bioventus Inc - Ordinary Shares - Class A was a trade of 466,054 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on March 14, 2022.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Bioventus Inc - Ordinary S... | Kenneth M. Reali | Director, Fmr. CEO and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2022 | 466,054 | 466,054 | - | - | Stock Option (Right to Buy) | |
Bioventus Inc - Ordinary S... | Kenneth M. Reali | Director, CHIEF EXECUTIVE OFFICER | Purchase of securities on an exchange or from another person at price $ 14.81 per share. | 09 Sep 2021 | 1,800 | 11,175 (0%) | 0% | 14.8 | 26,658 | Class A Common Stock |
Bioventus Inc - Ordinary S... | Kenneth M. Reali | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2021 | 30,000 | 30,000 | - | - | Stock Options | |
Bioventus Inc - Ordinary S... | Kenneth M. Reali | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 13.00 per share. | 11 Feb 2021 | 9,375 | 9,375 (0%) | 0% | 13 | 121,875 | Common Stock |